Consider short strangle for Sun Pharma

K.S. Badri Narayanan | Updated on May 18, 2020 Published on May 18, 2020

The long-term outlook still remains negative for Sun Pharmaceuticals (Rs 448), as long as it rules below Rs 628. However, the medium-term outlook turned positive for Sun Pharma while in the short-term it will move in a narrow range before pursuing a positive journey. The stock finds immediate resistance at Rs 477 and support at Rs 404. A close below the latter would drag Sun Pharma to Rs 365 and even to Rs 332. On the other hand, a conclusive end above Rs 447 has the potential to list the stock to Rs 525 and also to Rs 585.

F&O Pointers: Sun Pharma futures shed open positions last week along with fall in share prices. This signals, traders prefer to book profits rather than rolling over positions. Option trading signals that the stock could move in the range of Rs 350-500.

Strategy: We advice traders to consider a short strangle on Sun Pharma. This can be constructed by selling 550-call and 350-put, which closed with a premium of Rs 1.65 and Rs 1.55 respectively. As the market lot is 1,250 shares per contract, this would result in an inflow of Rs 4,000 to the trader, which would be a maximum profit one can earn. For that to happen, Sun Pharma has to settle between Rs 350 and Rs 550.

A close above Rs 553.20 or a close below Rs 346.80 will start affecting the position. As selling options involve huge margin money and could result in a heavy loss (if Sun Pharma moves in a single direction - either up or down violently), we advise this strategy os for traders who can withstand the risk and wild swings.

Hold the position till expiry.

Hold Nifty-50 9500 call option as advised last week.

(Note: The recommendations are based on technical analysis and F&O positions. There is a risk of loss in trading.)

Published on May 18, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.